RecruitingNot ApplicableNCT07398391

Blood Pressure Care for Advancing Real-World Evidence (BPCARE)

Blood Pressure Care for Advancing Real-World Evidence (BPCARE): an RCT of Adherence


Sponsor

University of California, San Diego

Enrollment

250 participants

Start Date

Jan 9, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this randomized clinical trial is to determine whether a community health worker-delivered, multi-component behavioral intervention can improve antihypertensive medication adherence and blood pressure control among adult refugees with hypertension who are prescribed antihypertensive medications. The main questions it aims to answer are: 1. Does participation in the BPCARE intervention improve antihypertensive medication adherence compared to enhanced usual care? 2. Does participation in the BPCARE intervention improve blood pressure control and persistence over time compared to enhanced usual care? Researchers will compare participants randomized to the BPCARE intervention to those receiving enhanced usual care (hypertension information and a home blood pressure monitor) to determine the effects on medication adherence, blood pressure control, and persistence. Participants will: * Be randomly assigned to either the BPCARE intervention or enhanced usual care * Receive hypertension education and a home blood pressure monitor * Participate in community health worker-delivered sessions that include hypertension and medication education, motivational interviewing, problem-solving, and action planning (intervention arm only) * Complete questionnaires assessing medication adherence and related psychosocial factors * Have blood pressure monitored using connected home blood pressure devices * Complete pill counts to assess medication adherence over a nine-month follow-up period


Eligibility

Min Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This study is building a real-world evidence database to better understand how hypertension (high blood pressure) is managed in people for whom English is a second language. Researchers will track blood pressure readings and treatment patterns to identify gaps in care and improve outcomes for this population. **You may be eligible if...** - You are 21 or older - You have been diagnosed with high blood pressure - English is your second language - You have had a recorded blood pressure reading of 130 mmHg (systolic) or higher in the past year, or a home reading of 140 mmHg or higher - You are willing to give written consent and participate in study activities **You may NOT be eligible if...** - You are unable to give informed consent - You have conditions that would make it unsafe to participate in blood pressure monitoring activities - You are not able to participate in study procedures Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALBPCARE Intervention

Participants randomized to the BPCARE intervention will receive a culturally and linguistically tailored hypertension-education booklet, a pill organizer to support medication adherence, and two structured intervention sessions focused on medication adherence delivered within month 1 and 2 after randomization. These sessions include individualized counseling on blood pressure management, medication adherence strategies, and lifestyle modification. Participants will also receive ongoing follow-up and support from trained Patient Health Navigators (PHNs), including check-ins, problem-solving assistance, and linkage to additional resources as needed.


Locations(2)

University of California, San Diego

San Diego, California, United States

Family Health Centers of San Diego

San Diego, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07398391


Related Trials